Top

Ablynx

Ablynx (Euronext Brussels: ABLX) is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases, including inflammation, haematology, oncology and pulmonary disease.

The Company is headquartered in Ghent, Belgium.

www.ablynx.com